Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Dec 28.
Published in final edited form as: J Nat Prod. 2012 Dec 17;75(12):2168–2177. doi: 10.1021/np300603z

Diarylheptanoids from Dioscorea villosa (Wild Yam)

Shi-Hui Dong 1, Dejan Nikolić 1, Charlotte Simmler 1, Feng Qiu 1, Richard B van Breemen 1, Djaja D Soejarto 1, Guido F Pauli 1, Shao-Nong Chen 1,*
PMCID: PMC3710746  NIHMSID: NIHMS481018  PMID: 23245349

Abstract

A fractionation methodology aimed at the metabolomic mining of new phytoconstituents for the widely used botanical, wild yam (Dioscorea villosa), makes use of 1D qHNMR and 2D NMR profiles along the preparative fractionation pathway. This quantifiable and structural guidance led to the isolation of 14 diarylheptanoids (114), including five new compounds (15) with a tetrahydropyrano core skeleton. The structures, including the absolute configurations of both new and previously known diarylheptanoids, were assigned by a combination of HRESIMS, 1D and 2D NMR, 1H iterative full spin analysis (HiFSA), and the Mosher’s ester method. The isolation yields were consistent with yields predicted by qHNMR, which confirms the (semi-)quantifiable capabilities of NMR-based preparative metabolomic mining. The qHNMR-aided approach enabled the identification of new and potentially significant chemical entities from a small fraction of the plant extract and, thereby, facilitated the characterization of the residual complexity of the D. villosa secondary metabolome. LC-MS profiling of different D. villosa accessions further confirmed that the diarylheptanoids represent genuine secondary metabolites, which can serve as a new class of markers for botanical integrity analysis of D. villosa.


The genus Dioscorea in the family Dioscoreaceae comprises over 600 species, which are found throughout the tropical and temperate regions of the world. Dioscorea species are widely used as botanical dietary supplements. These plants are well known for containing steroidal saponins, which have been used as marker compounds for quality control of the botanical products.1 The roots and rhizomes of Dioscorea villosa L. are known as “wild yam”. This species, native to North America, is a twining tuberous vine. Since the 18th century, herbalists have been using wild yam to treat menstrual cramps and problems related to childbirth, as well as for upset stomach and coughs.2 In 1940, the rhizomes of D. villosa were discovered to be an important source of diosgenin,3 a phytoestrogen that acts on the mammary epithelium of ovariectomized mice and can be chemically converted into the mammalian hormone, progesterone.4-6 Subsequently, diosgenin was used as starting material for the synthesis of cortisone and norethindrone.7 The latter became known as a highly potent and orally active progestational agent and was the key ingredient in the first birth control pills in the 1960s.7

Today, dietary supplements containing wild yam extracts are popular among women for the alleviation of menopausal symptoms and are widely used as alternatives to hormone replacement therapy, although no direct evidence exists for the estrogenic activity of wild yam extracts.8,9 A comprehensive literature survey reveals that phytochemical information on wild yam is limited in chemical diversity: so far, only 12 steroidal saponins and two flavan-3-ol glycosides having been reported as major secondary metabolites.1,3,10-12 From both chemotaxonomic and metabolomic perspectives, Dioscorea species can also be considered underexplored and likely contain other classes of secondary metabolites. The relatively narrow spectrum of known phytoconstituents limits our current understanding of the significance of wild yam as a dietary supplement, in particular with regard to the potential relief of menopausal symptoms. In addition to considering the relevance of residual complexity (RC; see ref 13 and S1, Supporting Information) in the assessment of phytoconstituents from D. villosa, and plant metabolomes in general, the present study also took into account the role of alternative chromatography in the discovery of new classes of secondary metabolites, as has been shown for well-studied plants such as black cohosh (Actaea racemosa (L.) Nutt., syn. Cimicifuga racemosa L.).14 As part of the research in the UIC/NIH Botanical Center, aimed at the metabolomic mining of new and potentially interesting bioactive constituents, the present study explores preparative fractionation methodology, which utilizes the combination of both 1D and 2D NMR spectral profiles and diversified chromatography. One starting point was the 1H NMR spectrum of the MeOH extract of wild yam, which is dominated by the signals of the steroidal saponins and saturated lipids in the range between δ 0.5 and 6.0. Figure 1 shows that, under higher sensitivity NMR conditions, numerous minor resonances can be detected between δ 6.0 and 8.5, which cannot be assigned to known Dioscorea constituents. Using qHNMR, an enrichment efficiency parameter (see Results and Discussion) was established to guide the fractionation workflow toward the isolation of the putatively new aromatic metabolites.

Figure 1.

Figure 1

Figure 1

Representation of the concept of 1H NMR-guided fractionation for the metabolomic mining of Dioscorea phytoconstituents. A 30 mg aliquot of crude MeOH extract of wild yam was carefully dried in vacuo, dissolved in 600 μL of DMSO-d6, and a high S/N 1H NMR spectrum collected (400 MHz, 5 mm broadband probe with ATM, NS = 5 K). Under these conditions, signals in the aromatic region between δH 6.0 and 8.5 (2.47%) were readily detected and some of them could even be recognized as diagnostic AA′XX′ resonances of the subsequently isolated diarylheptanoids.

Primary fractionation of the crude MeOH extract used a MeOH-H2O solvent gradient on a preparative C18 solid phase extraction (SPE) cartridge and effectively enriched the aromatic components into three fractions, which were further purified by VLC, MPLC, and HPLC. The resulting 14 aromatic compounds include both new tetrahydropyrano (15) and acyclic (614) diarylheptanoids, marking the first report of members of this metabolite class from D. villosa.15 Structure elucidation was performed to the level of absolute configuration on the basis of 1D and 2D NMR data, 1H iterative full spin analysis (HiFSA), advanced Mosher’s ester analysis, and chiral HPLC. Furthermore, LC-MS profiling confirmed that the diarylheptanoids represent genuine secondary metabolites of wild yam (S2, Supporting Information).

The occurrence of diarylheptanoids in the genus Dioscorea was first discovered in 2004,16 reporting three such compounds from D. spongiosa, a species which had been previously authenticated as D. septemloba.17 Since then, two additional analogues have been reported from D. spongiosa18 and one from D. bulbifera.19 Diarylheptanoids are well-known and major secondary metabolites from the Zingiberaceae. They possess a 1,7-diphenylheptane skeleton and exhibit prominent pharmacological activities such as estrogenic, anticancer, antibacterial, anti-oxidative, anti-inflammation, and anti-osteoporotic properties.15 The first diarylheptanoid to be discovered was curcumin, a yellow pigment from turmeric (Curcuma longa L., Zingiberaceae) first purified in 1815.15 Curcumin has been studied extensively both in vitro and in vivo, including human clinical trials for a variety of diseases, e.g., multiple myeloma, pancreatic cancer, myelodysplastic syndromes, colorectal cancer, psoriasis, and Alzheimer’s disease.15,20-22 Considering the immense body of existing research evidence, the present metabolomic mining of a variety of diarylheptanoids in wild yam widens the biochemical profile of Dioscorea plants and potentially offers new biochemical leads for the development of wild yam and other Dioscorea botanical products. Herein, we present the details of the isolation methodology and the structure elucidation of these new diarylheptanoids.

RESULTS AND DISCUSSION

Targeted Purification

The purification scheme that yielded the diarylheptanoids started with the EtOAc partition of the MeOH extract of D. villosa roots/rhizomes. A suspension of this partition in MeOH-H2O (1:9, v/v) was loaded on a vacuum SPE cartridge containing C18-RP silica gel as a packing material. Eleven primary fractions were collected, from elution with a gradient of a MeOH-H2O solvent system from 0:10 to 10:0 in 10% intervals. The 1H NMR spectra of all primary fractions were examined for the abundance of aromatic resonances. In order to establish a quantifiable measure for the enrichment of the unknown aromatic metabolites, the resonances of the steroidal methyl groups appearing between δ 0.5 and 1.3 were used as an internal reference and the integral ratio of the unexplored aromatic region (δ 6.0 to 8.5) relative to the lipophilic region (δ 0.5 to 1.3) was calculated (see Extraction and Isolation in Experimental section as well as S3, Supporting Information). This value was determined for both the extract and the primary fractions and allowed monitoring of the relative content of the aromatic target compounds, thus, serving as the enrichment efficiency parameter. The most concentrated aromatic fractions, 4-6, were combined for further purification by VLC, MPLC, and HPLC. The purification scheme eventually afforded 14 diarylheptanoids (114), five of which (15) were new compounds containing a tetrahydropyrano ring in the heptane portion of the molecule. The absolute configurations of 6 and 7 were assigned for the first time. The presence of enantiomeric pairs in four of the purified products (2/3, 4/5, 6/7, and 8/9) was only recognized during the effort to assign their individual absolute configurations using the advanced Mosher’s ester method. The generation of HiFSA data sets (see subsection General Experimental Procedures in the Experimental Section) for 17 (S4, Supporting Information) aided the unambiguous assignments of the partially complex 1H NMR signals and, thus, was instrumental in the interpretation of the chiral NMR experiments. Moreover, the confirmation of δ and J values (Table 1) by HiFSA to 0.1 ppb and 0.01 Hz precision, respectively, provided valuable data for unambiguous future structure dereplication of these compounds.

Table 1.

1H and 13C NMR Spectroscopic Data of Compounds 17a,b

Pos. 1c 2/3 4/5 6/7

δH, mult.
(J in Hz)
δC, mult. δH, mult.
(J in Hz)
δC, mult δH, mult.
(J in Hz)
δC, mult. δH, mult
(J in Hz)
δC, mult.
1 4.8376, dd (11.96, 2.06) 75.20, CH 4.7013, dd (11.87, 2.12) 75.03, CH 4.2506, dd (11.42, 1.98) 78.87, CH 7.5634, d (16.12) 145.69, CH
1.8153, ddd (13.62, 11.96, 2.88) 40.97, CH2 1.7637, ddd (13.88, 11.87,
2.74)
41.03, CH2 1.4305, ddd (12.42, 11.42, 11.01) 43.73,
CH2
6.6649, d (16.12) 124.64, CH
1.8396, dddd (13.62, 3.00, 2.06,
2.05)
1.8334, dddd (13.88, 3.32,
2.12, 2.09)
2.0715, dddd (12.42, 4.51, 1.98,
1.82)
3 4.2864, dddd (quintet) (3.00, 2.88,
2.82, 2.67)
65.47, CH 4.2303, dddd (quintet) (3.32,
2.89, 2.74, 2.40)
65.74, CH 3.8294, dddd (11.01, 11.00, 4.60,
4.51)
69.19, CH 202.08, C
1.7286, ddd (13.96, 11.70, 2.82) 39.61, CH2 1.5415, ddd (13.82, 11.59,
2.89)
39.37, CH2 1.2226, ddd (12.30, 11.22,
11.00)
41.99,
CH2
2.8516, dd (15.41, 8.26) 48.89, CH2
1.8323, dddd (13.96, 2.67, 2.28,
2.05)
1.7070, dddd (13.82, 2.55,
2.40, 2.09)
1.9539, dddd (12.30, 4.60, 1.97,
1.82)
2.7743, dd (15.41, 4.35)
5 4.5942 dddd (11.70, 6.43, 2.28,
1.09)
74.76, CH 3.9099, dddd (11.59, 9.37,
5.25, 2.55)
72.81, CH 3.4428, dddd (11.22, 7.88, 5.27,
1.97)
76.49, CH 4.0991, dddd (8.26, 7.84,
4.47, 4.35)
68.98, CH
6 6.0619 dd (15.96, 6.43) 128.45, CH 1.7815, dddd (13.75, 8.97,
8.52, 5.25)
39.66, CH2 1.8507, dddd (13.59, 9.17, 7.36,
5.27)
39.41,
CH2
1.7671, dddd (13.56, 9.53,
6.90, 4.47)
40.71, CH2
1.6553, dddd (13.75, 9.37,
7.73, 4.73)
1.7270, dddd (13.59, 9.18, 7.88,
5.02)
1.7531, dddd (13.56, 9.11,
7.84, 6.30)
7 6.5327, dd (br d) (15.96, 1.09) 131.57, CH 2.6582, ddd (13.95, 8.97,
4.73)
31.94, CH2 2.6630, ddd (13.80, 9.17, 5.02) 31.99,
CH2
2.7028, ddd (13.87, 9.11,
6.90)
32.14, CH2
2.6012, ddd (13.95, 8.52,
7.73)
2.6102, ddd (13.80, 9.18, 7.36) 2.5912, ddd (13.87, 9.53,
6.30)
1′ 135.04, C 135.36, C 134.77, C 127.39, C
2′,6′ 7.2145, dd (dt-like) (8.37, 2.47) 128.74, CH 7.2005, dd (dt-like) (8.41,
2.54)
128.71, CH 7.1994, dd (dt-like) (8.43, 2.38) 128.69,
CH
7.4891, dd (dt-like) (8.52,
2.52)
131.74, CH
3′,5′ 6.7539, dd (dt-like) (8.37, 2.70) 116.09, CH 6.7592, dd (dt-like) (8.41,
2.54)
116.10, CH 6.7623, dd (dt-like) (8.43, 2.71) 116.11,
CH
6.8160, dd (dt-like) (8.52,
2.51)
117.07, CH
4′ 157.90, C 157.94, C 158.07, C 161.76, C
1″ 130.02, C 134.56, C 134.37, C 134.30, C
2″,6″ 7.2283, dd (dt-like) (8.52, 2.63) 128.80, CH 6.9984, dd (dt-like) (8.27,
2.73)
130.54, CH 6.9941, dd (dt-like) (8.29, 2.32) 130.51,
CH
7.0243, dd (dt-like) (8.29,
2.74)
130.47, CH
3″,5″ 6.7141, dd (dt-like) (8.52, 2.74) 116.39, CH 6.6766, dd (dt-like) (8.27,
2.41)
116.20, CH 6.6803, dd (dt-like) (8.29, 2.76) 116.23,
CH
6.6918, dd (dt-like) (8.29,
2.46)
116.27, CH
4″ 158.27, C 156.45, C 156.50, C 156.53, C
a

Measured in methanol-d4 at 400 and 100 MHz, respectively.

b

Four and two decimal places were determined by HiFSA analysis for δH and J, respectively.

c

In order to improve the solubility, 10% CDCl3 was added.

Structure Elucidation

Compound 1 was obtained as a white, amorphous powder and its molecular formula was established as C19H20O4 on the basis of HRESIMS. Thus, the carbon skeleton required 10 indices of hydrogen deficiency. The 1H NMR spectrum of 1 (Table 1) exhibited the typical dt-like resonances of two aromatic AA′XX′ spin system at δH 7.228 and 6.714 (J = 8.5 and 2.6 Hz, each 2H), as well as 7.215 and 6.754 (J = 8.4 and 2.5 Hz, each 2H), respectively, indicating the presence of two p-disubstituted benzene rings. Accordingly, the 13C BB and DEPT NMR spectra of 1 (Table 1) exhibited four methine resonances at δC 128.80, 128.74, 116.09 and 116.39 (each 2C), as well as four quaternary carbon resonances at δC 158.27, 157.90, 135.04 and 130.02. Two proton resonances at δH 6.533 and 6.062 exhibiting a large coupling constant of 16.0 Hz were also observed in the 1H NMR spectrum of 1, indicating the presence of an E double bond. The 13C DEPT experiment demonstrated three oxygenated methines at δC 75.20, 74.76, and 65.47, along with two methylene groups at δC 40.97 and 39.61. These diagnostic NMR data clearly showed that 1 is a diarylheptanoid.15 The 1H-1H COSY NMR spectrum of 1 showed a continuous series of correlations from H-1 to H-7, indirectly establishing the C-C connectivity of the heptane moiety. The presence of an oxygen bridge between C-1 and C-5 and, thus, the tetrahydropyrano partial structure of the heptane moiety, were determined by the HMBC correlation from H-1 to C-5. Similarly, HMBC correlations of the H,C-pairs: H-2′/C-1, H-6′/C-1, H-1/C-1′, H-1/C-2′, H-1/C-6′, as well as H-2″/C-7, H-6″/C-7, and H-6/C-1″ linked the two benzene rings to their respective C-1 and C-7 positions of the heptane unit. Consequently, the two OH groups were assigned to C-4′ and C-4″, which is supported by their chemical shifts and the molecular formula. ROESY correlations observed between the four pairs of H-1/H-5, H-2α/H-4α, H-3/H2-2, and H-3/H2-4 indicated that the tetrahydropyrano ring assumes a chair conformation. The large coupling constants between H-1 and H-2α (J = 12.0 Hz) as well as H-5 and H-4α (J = 11.7 Hz) indicated the trans-diaxial positions of these protons, leaving equatorial positions for H-2β and H-4β in the tetrahydropyrano ring. This was supported by the occurrence of a W-type long-range coupling constant between H-2β and H-4β (4J = 2.1 Hz). H-3 was also demonstrated to be in an equatorial position by its quintet-like splitting pattern arising from only small coupling constants (dddd, J = 3.0, 2.9, 2.8 and 2.7 Hz). Finally, the advanced Mosher’s ester procedure23,24 was employed to determine the absolute configuration of C-3, bearing a secondary OH group. Treatment with (R)- and (S)-MTPA chlorides led to esterification of the secondary C-3 OH group to afford the (R)- and (S)-MTPA derivatives (1R and 1S), respectively. By observing the 1H NMR chemical shift difference values (ΔδS-R) of the heptane moiety, the absolute configuration of C-3 was determined to be S (Figure 2). Hence, the structure of 1 was elucidated as (1S,3S,5R,6E)-1,7-bis(4-hydroxyphenyl)-1,5-epoxy-3-hydroxyhept-6-ene.

Figure 2.

Figure 2

Figure 2

The ΔδS-R values of MTPA esters of 1, 4, 6 and 8 used for the determination of absolute condiguration.

Compounds 2 and 3 were purified in the form of an enantiomeric mixture by HPLC with an RP C18 column. As the 1H NMR spectrum of this mixture showed a purity of 94.8% assuming it was a single compound, 1D and 2D NMR spectra were recorded for the elucidation of the gross structure and relative configurations. The HRESIMS gave a molecular formula of C19H22O4. The 1H and 13C NMR data (Table 1) revealed that 2 and 3 were also diarylheptanoids and showed the characteristic resonances for two p-disubstituted benzene rings, three oxygenated methines, and four methylene groups. Using the same approach as for 1, utilizing 1H-1H COSY and HMBC spectra, the gross structures of 2 and 3 were determined to be 6,7-dihydro derivatives of 1, a finding consistent with the molecular weight and presence of two additional mass units. Upon comparison of the two 1H NMR data sets of 1 and 2/3, the observation of congruent splitting patterns of the signals of H-1, H-3, and H-5 indicated that the compounds have identical relative configurations, which was supported by the ROESY correlations of the pairs H-1/H-5, H-3/H2-2, and H-3/H2-4.

In order to determine the absolute configuration of C-3 in the original isolate (eventually determined to be an enantiomeric mixture of 2 and 3), the (R)- and (S)-MTPA derivatives were prepared, which exhibited two very similar 1H NMR spectra. The only noticeable difference was the reversed integration ratio of two sets of resonances in a ratio of 52.4:47.6, indicating that this sample is indeed an enantiomeric mixture of compounds, 2 and 3.25,26 In the 1H NMR spectra of the two MTPA derivatives, the resonances of H-1 and H-3 could be clearly assigned based on their chemical shifts and splitting patterns (Figure 3). Owing to the MTPA acylation, the H-3 resonances of the derivatives overlapped at much lower field. The phenyl ring of the MTPA moiety exhibited the smallest shielding/deshielding effect on H-3 and did not produce diastereotopic dispersion. In contrast, the esterification widened the diastereotopic dispersion of the two H-1 resonances, yielding two separate signals with different integrations, 52.4:47.6, which was used to determine the ratio of two parent enantiomers (Figure 3). Subsequently, the chemical shift difference of the two H-1 resonances was used to assign the absolute configuration of C-3: as the ΔδS-R values of the H-1 resonances in the major and minor diastereomers were +0.221 and –0.221 ppm, respectively, the absolute configurations of C-3 of the two parent enantiomers had to be S and R, respectively (Figure 3). Thus, the structures of 2 and 3 were deduced as (1S,3S,5S)-1,7-bis(4-hydroxyphenyl)-1,5-epoxy-3-hydroxyheptane and (1R,3R,5R)-1,7-bis(4-hydroxyphenyl)-1,5-epoxy-3-hydroxyheptane, respectively. In further support of this finding, the enantiomeric mixture of 2 and 3 was separated by normal phase HPLC on a chiral column (Chiralcel® OJ; 10 μm, 250 × 4.6 mm) as shown in Figure 4. Using UV detection at 224 nm, the peak areas of the two enantiomers were calculated to give an abundance ratio of 47.6:52.4, which was fully consistent with the chiral qHNMR determination (compounds 3 to 2).

Figure 3.

Figure 3

Comparison of the 1H NMR spectra of the MTPA esters of the enantiomeric mixture of 2 and 3 (δH 4.5 to 5.8). The resonances of H-1 and H-3 could be readily assigned based on their chemical shifts and splitting patterns. However, the four resonances of H-1 revealed a small but significant difference in their integrals (47.6:52.4, and vice versa), providing evidence for the fact that the isolate was an enantiomeric mixture of 2 and 3 rather than a pure single enantiomer.

graphic file with name nihms-481018-f0006.jpg

Figure 4. Chiral separation of three pairs of enantiomers (2/3, 4/5 and 6/7) by HPLC (2/3 and 6/7: Chiralcel® OJ, 10 μm, 250 × 4.6 mm; 4/5: Chiralpak® IA, 5 μm, 250 × 4.6 mm)

Similarly, compounds 4 and 5 were also obtained as an enantiomeric mixture, recognized upon 1H NMR analysis of their MTPA derivatives. The isolates gave the same molecular formula, C19H22O4, based on HRESIMS. The 1H and 13C NMR spectra of 4/5 showed the diagnostic signals of a diarylheptanoid, in which resonances for two p-disubstituted benzene rings, three oxygenated methines, and four methylene groups were observed (Table 1). Analysis of the 1H-1H COSY and HMBC spectra led to the same gross structure as that of 2 and 3. The coupling patterns of the tetrahydropyrano protons H-1, H-3 and H-5 indicated that all three protons assume axial positions in the chair-like conformer, which was further supported by the NOESY correlations of the pairs H-1/H-3, H-3/H-5, and H-5/H-1. Using the same method described for 2/3, 1H NMR analysis of the (R)- and (S)-MTPA derivatives, the absolute configurations of C-3 in 4 and 5 were determined to be R and S, respectively (Figure 2). Thus, the structures of 4 and 5 were determined as (1S,3R,5S)-1,7-bis(4-hydroxyphenyl)-1,5epoxy-3-hydroxyheptane and (1R,3S,5R)-1,7-bis(4-hydroxyphenyl)-1,5-epoxy-3-hydroxyheptane, respectively. Shown in Figure 4, the enantiomeric pair 4/5 could also be separated by normal phase HPLC on a chiral column (Chiralpak® IA; 5 μm, 250 × 4.6 mm). The peak areas of the two enantiomers at UV 216 nm were used to calculate their relative abundance ratio as 83.7:16.3. The qHNMR evaluation of the (R)- and (S)-MTPA derivatives resulted in a different ratio of 76.2:23.8. This observed difference between UV and qHNMR results might partially be due to UV-active impurities, but most likely resulted from the quantification error of the qHNMR assay in this particular case. As shown only recently,27 both the accuracy and the precision of qHNMR quantification depend on the signal to noise ratio (S/N), leading to an overestimation of content and higher errors as the S/N drops below 150. Under the chosen conditions (~300 μg sample, 600 μL, 5mm RT broadband probe, 400 MHz), the qHNMR spectra of the MTPA derivatives exhibited a S/N of 13 for the minor diastereomer (~20%) in an already mass limited sample. The conclusion that the qHNMR-based content is likely too high is consistent with observations made in the recent qHNMR validation study27 and supports the UV-based enantiomeric ratio as being more reliable in this case.

Compounds 6 and 7 were also obtained as an enantiomeric mixture and further separated by normal phase HPLC using the same chiral column as for 2 and 3 (Figure 4). While the peak areas of HPLC at UV 213 nm showed an enantiomeric ratio of 57.2:42.8, overlap of 1H NMR resonances of the pairs of (R)- and (S)-MTPA esters did not allow qHNMR quantification. The molecular formula of 6 and 7 was determined to be C19H20O4 using HRESIMS. Interpretation of the 1H and 13C NMR spectra (Table 1) suggested identity with a previously reported gross structure, 5-hydroxy-1,7-bis(4-hydroxyphenyl)-1-hepten-3-one, for which no absolute configuration assignment had been made.28 Two aliquots of the major enantiomer, 6, were treated with (R)- and (S)-MTPA chlorides to form diastereomeric derivatives. Analysis of their 1H and 1H-1H COSY NMR spectra indicated that 6 has the 5R configuration; accordingly, the minor enantiomer possesses the 5S configuration (Figure 2). Similarly, the structures of 6 and 7 were elucidated as (5R,1E)-1,7-bis(4-hydroxyphenyl)-5-hydroxyhept-1-en-3-one and (5S,1E)-1,7-bis(4-hydroxyphenyl)-5-hydroxyhept-1-en-3-one, respectively.

Seven previously reported diarylheptanoids (8-14) were characterized from D. villosa for the first time. Compounds 8 and 9 were obtained as enantiomeric mixtures (64.5:35.5) and determined to be (5S)-1,7-bis(4-hydroxyphenyl)-5-hydroxyheptan-3-one and (5R)-1,7-bis(4-hydroxyphenyl)-5-hydroxyheptan-3-one, respectively,29,30 by analysis of their NMR and MS data as well as by a Mosher’s ester analysis (Figure 2); three diarylheptanoids 10-12 were assigned as (4E,6E)-1,7-bis(4-hydroxyphenyl)hepta-4,6-dien-3-one,31 (3R*,5S*)-1,7-bis(4-hydroxyphenyl)-3,5-dihydroxyheptane,32 and (3R,5R)-1,7-bis(4hydroxyphenyl)-3,5-dihydroxyheptane,33 respectively, by comparing their NMR and optical rotation data with those in the literature; compounds 13 and 14 were obtained as a mixture (separable, but interconverting) in the ratio 87.3:12.7 as determined by qHNMR, and their structures were elucidated as (4Z,6E)-1,7-bis(4-hydroxyphenyl)-5-hydroxyhepta-4,6-dien-3-one and (1E)-1,7-bis(4-hydroxyphenyl)hept-1-ene-3,5-dione, respectively,31,34 by 1D and 2D NMR as well as MS analysis.

Stereochemical and Full Spin Analysis

While the advanced Mosher’s ester method was efficient for the determination of the absolute configuration of diarylheptanoids bearing secondary OH groups (19), the method was unsuitable for the symmetric compounds 11 and 12, as the proton resonances surrounding the OH group(s) in the derivatives could not be unambiguously assigned. However, the absolute configuration of enantiomers could be assigned in analogy with that of 2/3, 4/5 and 8/9 by analyzing the 1H NMR spectra of their mixed (R)- and (S)-MTPA esters. In general, enantiomeric ratios can be determined by integration of 1H resonances, provided the isolates exhibit some degree of enantiomeric excess and the MTPA derivatives show sufficiently disperse diastereotopic proton signals.

Finally, in order to facilitate the future structural dereplication of congeneric diarylheptanoids from Dioscorea species, as well as analogues from other genera such as Alpinia, Zingiber, Curcuma, and Alnus, but also to support development of qHNMR standardization protocols, the precise 1H NMR profiles of the newly characterized botanical markers were generated by means of HiFSA, using the PERCH software tool, for compounds 1, 2/3, 4/5 and 6/7.35 Molecular structures of the selected diarylheptanoids were used as starting points to analyze each discrete spin system and predict the basic 1H NMR parameters (δ and J). Then, the predicted NMR parameters were optimized through iterative spin system calculations using the PERCHit iterator, until the quantum-mechanical simulations replicated the experimental 1H NMR spectra (S4, Supporting Information). The final simulated HiFSA spectra exhibited excellent agreement with the observed spectra for all spectral lines and line intensities, with a total root-mean-square deviation (RMSD, “residual”) of less than 0.07%. These results further validated the elucidated structures (S4, Supporting Information). The simulated HiFSA spectra represent highly precise fingerprints, which can be used to, unambiguously, identify the marker compounds and distinguish their resonances from those of impurities by comparison with the experimental spectra. This enables qHNMR-based determination of content,35 sample purity,36,37 and purity-activity investigation.38 The digital HiFSA spectra of these secondary metabolomic markers can also serve as references for future metabolomic standardization of wild yam botanicals.35

Diarylheptanoids in Dioscorea villosa

While diarylheptanoids are mainly distributed in the roots, rhizomes, and bark of Alpinia, Zingiber, Curcuma, and Alnus species,15 this is the first report of this compound class from the rhizomes/roots of Dioscorea villosa. Taking into account existing evidence for the presence of diarylheptanoids in the genus Dioscorea, it was still important to confirm that diarylheptanoids represent genuine secondary metabolites of wild yam. The LC-MS profiling performed in the present study detected the most abundant diarylheptanoid, 12, in the crude extract of an authentic, in-house cultivated wild yam specimen (S2, Supporting Information). Additional evidence for the genuine presence of diarylheptanoids in wild yam came from characteristic correlation patterns in the aromatic region of the 1H-1H COSY NMR spectra of the crude extract, matching those of the isolates (S56, Supporting Information).

With respect to the preparative mining of secondary metabolites, the use of 1H NMR-based information about structural fragments was shown to provide valuable guidance for the development of purification protocols. Combined with diverse chromatographic methodology, this approach facilitates the discovery of previously unknown and/or potentially interesting metabolites, even from relatively well-studied plants or other complex biological matrices. Once specific proton resonances have been identified and linked to a characteristic structural class or partial structure, a tailored and more targeted fractionation protocol can be developed, as is shown here for a series of mostly new diarylheptanoids from a widely used botanical.

In addition to providing qualitative guidance about the partial structure of unknown metabolites, the present approach is even capable of predicting isolation yields through qHNMR-based estimation of their contents.39 The major diarylheptanoid, 12, was estimated to be present at a concentration of 0.045%, which compares well with the isolation yield of 0.023% (230 ppm, 205.0 mg from 900 g of extract), especially when considering unavoidable loss during the four-step isolation procedure. Similarly, minor aromatic signals, such as the typical 2H pseudo-.doublets of AA′XX′ spin system, allowed the prediction of isolation yields below 0.002% (< 20 ppm) for further diarylheptanoids, which again matches the achieved yields of 0.8-15.2 mg for the other isolates, 111, 13, and 14. These preliminary results indicate that the assumptions about proton and molar ratios required for performing the qHNMR calculations are valid for practical purposes and allow a reasonably close prediction of both individual yields and required scale for the isolation procedure.

Concluding Remarks

While the biological impact and potential of the wild yam diarylheptanoids require further study, which is ongoing in our laboratory, the present report establishes a link between the ubiquitous residual complexity (RC) of crude metabolomes, such as plant extracts, and the approach of qHNMR-guided metabolomic mining. These findings not only extend the utility of qHNMR applications, but also complement previous conclusions about the relevance of RC. For example, the RC of a clinical black cohosh extract was only uncovered after using a pH-targeted approach (pH zone refinement CPC) which led to the identification of N-containing metabolites, including the serotonergic active principle contained in the plant.14

Another link relates to the dereplication and targeted analysis of individual metabolites in residually complex samples. As has been shown for the structurally diverse triterpenes of black cohosh, rapid dereplication can be achieved from standard (q)HNMR spectra of (residually) complex mixtures, provided that characteristic and coherent spectroscopic information is available.13 By presenting the HiFSA profiles of compounds, 17, the present study facilitates future studies of Dioscorea botanicals at the chemistry/biology interface by supplying comprehensive information for dereplication. As shown recently, this knowledge also enables the precise quantification of multiple marker compounds by a combination of HiFSA and qHNMR,35 thus laying the groundwork for the quantifiable assessment of the RC of Dioscorea preparations.

EXPERIMENTAL SECTION

General Experimental Procedures

Optical rotations were measured on a Perkin-Elmer 241 polarimeter at 22 °C in MeOH. UV spectra were acquired on a Molecular Devices Spectra Max Plus 384 spectrophotometer. IR spectra were acquired on a Perkin-Elmer 577 IR spectrometer. For this purpose, MeOH solutions of the compounds were dripped onto the IR sample holder and evaporated to form a thin sample film. NMR spectra were obtained on a Bruker AV-400 (5 mm broadband probe with Automatic Tuning and Matching (ATM) capability) or a DPX-400 (5 mm 1H/13C/31P/19F QNP probe) NMR spectrometer (Bruker, Zürich, Switzerland) using methanol-d4 (for compound 1, by adding 10% CDCl3), pyridine-d5, or DMSO-d6 as the solvent. The chemical shifts of the residual solvent signals (δH 3.310 and δC 49.15 for methanol-d4; δH 8.740 for pyridine-d5; δH 2.500 for DMSO-d6) were used as the chemical shift reference and also as internal calibrants for qHNMR quantification. Offline NMR data processing was performed with MestReNova software version 8.0.0-10524 for Windows OS (Mestrelab Research, Santiago de Compostela, Spain). All NMR experiments were performed using standard Bruker pulse sequences. The 1H NMR data were processed with double zero-filling and Lorentz-Gauss resolution enhancement (LB −1.8 Hz and GF 0.04 = GB 1.0 Hz) prior to Fourier Transformation. Calculations for the 1H NMR iterative Full Spin Analysis were performed with the PERCH software package v.2010.1 (PERCH Solutions Ltd., Kuopio, Finland). HRESIMS was carried out on a Waters Q-TOF Synapt mass spectrometer using the negative mode. LC-MS analysis for study of the genuine nature of diarylheptanoid, 12, was performed on an AB Sciex 4000 LIT QTRAP® equipped with a Shimadzu UFLC system using a YMC-Pack ODS-AQ column (150 × 2.1 mm, 3 μm, 12 nm), with the ESI ion source operating in the positive mode.

Semi-preparative HPLC was carried out using a Waters 600 controller with a Waters 2996 photodiode array detector, using YMC-Pack ODS-AQ (250 × 10 mm, S-5, 12 nm), Chiralcel® OJ (250 × 4.6 mm, 10 μm), and Chiralpak® IA (250 × 4.6 mm, 5 μm) columns. Silica gel (230–400 mesh, Macherey-Nagel), C18 reversed-phase silica gel (Macherey-Nagel), Sephadex LH-20 (Sigma) and HW-40F gel (Tosoh) were used for VLC and MPLC. General fraction monitoring following preparative chromatographic separations was done by TLC analysis with pre-coated glass TLC plates (250 μm thickness, K6F Si gel 60, EM science, Germany). The compounds were visualized by spraying the dried plates with 5% H2SO4 in EtOH, followed by heating at 120 °C for 10 min. All solvents used for LC were of analytical and chromatographic grade purchased from Sigma-Aldrich Co., St. Louis, USA. The (R)- and (S)-MTPA chlorides were purchased from the same vendor.

Plant Material

Wild harvested rhizomes/roots of Dioscorea villosa L. (4.5 kg) were purchased from Mountain Rose Herbs in August 2011. Authentic rhizomes/roots of in-house cultivated D. villosa L. were collected in the UIC Dorothy Bradley Atkins Medicinal Plant Garden in October 2010. Both samples were authenticated by Dr. Djaja D. Soejarto of the Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago. A voucher specimen of the commercial sample (accession number: BC630) has been deposited at the Field Museum of Natural History Herbarium, Chicago, IL.

Extraction and Isolation

Authentic, in-house cultivated D. villosa (BC 601, 5 g) was extracted with MeOH to give 980.8 mg crude extract, of which 128.5 mg was subjected to an SPE VLC using 6 g of C18 reversed-phase silica gel as packing material. An eleven-step gradient of MeOH-H2O (0:10 to 10:0, v/v, 10% interval) was used as the mobile phase, and the 1H NMR spectra of all 11 fractions were examined in order to systematically explore the content of aromatic compounds. The integral ratio of two 1H NMR resonance regions, δH 6.0 to 8.5 and δH 0.5 to 1.3, was used as the parameter to measure the enrichment efficiency of the target compounds. The ratio was 5.3:94.7 in the MeOH extract, the ratios for the three primary fractions with the highest abundance of aromatic resonances were 45.0:55.0 (fr. 4), 34.2:65.8 (fr. 5) and 40.7:59.3 (fr. 6). Thus, fractions 4–6 were combined to give one enriched aromatic compounds fraction.

The dried and milled rhizomes/roots of D. villosa (BC 630, 4.5 kg) were extracted with MeOH (3 × 6000 mL) to give 900 g crude extract. This was suspended in H2O-MeOH (9:1), then, successively partitioned at room temperature between hexanes, CHCl3, EtOAc, and n-BuOH. Using the aforementioned enrichment strategy, the EtOAc-soluble partition (43.0 g) was subjected to a C18 SPE VLC, affording the enriched aromatic compounds fraction (2.4 g), which was chromatographed on a silica gel VLC eluted with a CHCl3/MeOH gradient (100:1 to 5:1, v/v) to give five secondary subfractions (A to E). Sub-fraction B was further fractionated by MPLC on HW-40F gel, eluted with MeOH to afford six tertiary subfractions (B-SF-I to B-SF-VI). Subfraction B-SF-V was subjected to a silica gel VLC, eluted with an isocratic SS (hexanes/acetone 2.5:1, v/v), to afford compound 10 (15.2 mg). Subfraction B-SF-VI was subjected to a silica gel VLC eluted with the isocratic SS of hexanes/EtOAc (1/1, v/v), to yield a mixture of compounds 13 and 14 (2.1 mg). The secondary subfraction C was chromatographed over silica gel by VLC, eluted with hexanes/EtOAc (2:1, v/v), and was further purified by LPLC on Sephadex LH-20 to afford the enantiomeric mixture of 8 and 9 (4.0 mg). The secondary subfraction D was subjected to MPLC on HW-40 gel, eluted with neat MeOH, to give four tertiary subfractions, D-SF-I to D-SF-IV. Subfraction D-SF-II was further separated by silica gel VLC, eluted with hexanes/EtOAc (3:1, v/v), to give five quaternary subfractions, D-SF-II-1 to D-SF-II-5. D-SF-II-2 was purified by a semi-preparative HPLC using C18 reversed phase and Chiralcel® OJ chiral columns successively, to give compounds 6 (3.8 mg) and 7 (3.2 mg), respectively. Fraction D-SF-II-2 was also purified by semi-preparative HPLC using reversed phase C18 and Chiralpak® IA columns successively, to yield compounds 4 (2.5 mg) and 5 (0.8 mg). The secondary subfraction E was purified by silica gel VLC, using isocratic elution with hexanes/EtOAc (1:1, v/v), to give 11 tertiary subfractions, E-SF-I to E-SF-XI. E-SF-VIII was determined to be a pure compound, 12 (205.0 mg). E-SF-V was purified by semi-preparative HPLC using a C18 reversed phase column, to give compounds 1 (3.3 mg), 11 (3.0 mg), and the enantiomeric mixture of 2 and 3, which was further separated into 2 (2.1 mg) and 3 (1.9 mg) by semi-preparative HPLC with a Chiralcel® OJ column. TLC fraction monitoring as described above was used throughout the separation process.

(1S,3S,5R,6E)-1,7-bis(4-hydroxyphenyl)-1,5-epoxy-3-hydroxyhept-6-ene (1)

white, amorphous powder; [α]D22 +14.6 (c 0.12, MeOH); UV (MeOH) λmax (log ε) 263 (4.49) nm; IR (MeOH) νmax 3342, 1611, 1515, 1238, 1020, 828 cm−1; 1H and 13C NMR data, see Table 1; HRESIMS negative mode: m/z 311.1289 [M – H] (calcd for C19H19O4, 311.1283).

(1S,3S,5S)-1,7-bis(4-hydroxyphenyl)-1,5-epoxy-3-hydroxyheptane (2)

white, amorphous powder; [α]D22 +190.2 (c 0.02, MeOH); UV (MeOH) λmax (log ε) 276 (3.90), 224 (4.65) nm; IR (MeOH) νmax 3310, 2922, 1614, 1515, 1236, 1172, 1070, 1031, 827 cm−1; 1H and 13C NMR data, see Table 1; HRESIMS negative mode: m/z 313.1446 [M – H] (calcd for C19H21O4, 313.1440).

(1R,3R,5R)-1,7-bis(4-hydroxyphenyl)-1,5-epoxy-3-hydroxyheptane (3)

white, amorphous powder; [α]D22 –166.7 (c 0.01, MeOH); UV (MeOH) λmax (log ε) 276 (3.90), 224 (4.65) nm; IR (MeOH) νmax 3336, 2922, 1614, 1515, 1232, 1172, 1069, 1030, 827 cm−1; 1H and 13C NMR data, see Table 1; HRESIMS negative mode: m/z 313.1446 [M – H] (calcd for C19H21O4, 313.1440).

(1S,3R,5S)-1,7-bis(4-hydroxyphenyl)-1,5-epoxy-3-hydroxyheptane (4)

white, amorphous powder; [α]D22 +32.9 (c 0.22, MeOH); UV (MeOH) λmax (log ε) 276 (3.54), 216 (4.39) nm; IR (MeOH) νmax 3336, 2944, 1614, 1515, 1449, 1367, 1236, 1066, 831 cm−1; 1H and 13C NMR data, see Table 1; HRESIMS negative mode: m/z 313.1448 [M – H] (calcd for C19H21O4, 313.1440).

(1R,3S,5R)-1,7-bis(4-hydroxyphenyl)-1,5-epoxy-3-hydroxyheptane (5)

white, amorphous powder; [α]D22 –30.6 (c 0.09, MeOH); UV (MeOH) λmax (log ε) 276 (3.54), 216 (4.39) nm; IR (MeOH) νmax 3336, 2944, 1614, 1515, 1449, 1367, 1236, 1066, 831 cm−1; 1H and 13C NMR data, see Table 1; HRESIMS negative mode: m/z 313.1448 [M – H] (calcd for C19H21O4, 313.1440).

(5R,1E)-1,7-bis(4-hydroxyphenyl)-5-hydroxyhept-1-en-3-one (6)

yellow, amorphous powder; [α]D22 +21.9 (c 0.10, MeOH); UV (MeOH) λmax (log ε) 327 (4.37), 213 (4.38) nm; IR (MeOH) νmax 3309, 2943, 1600, 1582, 1514, 1242, 1170, 1021, 819 cm−1; 1H and 13C NMR data, see Table 1; HRESIMS negative mode: m/z 311.1289 [M – H] (calcd for C19H19O4, 311.1285).

(5R,1E)-1,7-bis(4-hydroxyphenyl)-5-hydroxyhept-1-en-3-one (7)

yellow, amorphous powder; [α]D22 –18.1 (c 0.11, MeOH); UV (MeOH) λmax (log ε) 327 (4.37), 213 (4.38) nm; IR (MeOH) νmax 3310, 2940, 1598, 1581, 1514, 1204, 1169, 821 cm−1; 1H and 13C NMR data, see Table 1; HRESIMS negative mode: m/z 311.1289 [M – H] (calcd for C19H19O4, 311.1285).

Preparation of the (R)- and (S)-MTPA Ester Derivatives of 1

Two aliquots of compound 1 (0.3 mg each in 50 μL) were transferred into two NMR tubes and dried under vacuum overnight at room temperature. Then, 6 μL of (R)- or (S)-MTPA chloride and 600 μL of pyridine-d5 were successively added. The NMR reaction tubes were immediately sealed, shaken vigorously to ensure even mixing, and stored in a desiccator overnight until the reaction was complete. 1H NMR spectra were used to monitor the reaction. The 1H NMR spectra of the final (R)- and (S)-MTPA adducts were recorded directly after each reaction, and the chemical shifts were assigned based on 1H-1H COSY NMR experiments. Ambiguous signals were excluded from the calculation of ΔδS-R values 23,24.

1H NMR data of the (R)-MTPA ester of 1 (400 MHz, pyridine-d5) (S38, Supporting Information): δ 6.814 (1H, d, J = 15.9 Hz, H-7), 6.449 (1H, dd, J = 15.9, 5.5 Hz, H-6), 5.757 (1H, br quintet, J = 2.6 Hz, H-3), 4.715 (1H, dd, J = 11.8, 1.1 Hz, H-1), 4.621 (1H, m, H-5), 2.228 (1H, m, H-2a), 2.194 (1H, m, H-4a), 1.953 (1H, m, H-4b), 1.922 (1H, m, H-2b).

1H NMR data of the (S)-MTPA ester of 1 (400 MHz, pyridine-d5) (S40, Supporting Information): δ 6.764 (1H, d, J = 16.3 Hz, H-7), 6.430 (1H, dd, J = 16.3, 5.5 Hz, H-6), 5.765 (1H, br quintet, J = 2.8 Hz, H-3), 4.952 (1H, dd, J = 12.0, 2.2 Hz, H-1), 4.469 (1H, m, H-5), 2.264 (1H, m, H-2a), 2.169 (1H, m, H-4a), 1.993 (1H, m, H-2b), 1.903 (1H, m, H-4b).

Preparation of the (R)- and (S)-MTPA Ester Derivatives of 2 and 3

The (R)- and (S)-MTPA esters of the mixture of 2 and 3 obtained from the isolation scheme were produced by following the general Mosher reaction procedure described for 1.

1H NMR data of the (R)-MTPA ester of 2 (400 MHz, pyridine-d5) (S42, Supporting Information): δ 5.683 (1H, m, H-3), 4.603 (1H, dd, J = 11.6, 1.6 Hz, H-1).

1H NMR data of the (S)-MTPA ester of 2 (400 MHz, pyridine-d5) (S43, Supporting Information): δ 5.683 (1H, m, H-3), 4.824 (1H, dd, J = 11.6, 1.6 Hz, H-1).

1H NMR data of the(R)-MTPA ester of 3 (400 MHz, pyridine-d5) (S42, Supporting Information): δ 5.683 (1H, m, H-3), 4.824 (1H, dd, J = 11.6, 1.6 Hz, H-1).

1H NMR data of the (S)-MTPA ester of 3 (400 MHz, pyridine-d5) (S43, Supporting Information): δ 5.683 (1H, m, H-3), 4.603 (1H, dd, J = 11.6, 1.6 Hz, H-1).

Preparation of the (R)- and (S)-MTPA Ester Derivatives of 4 and 5

The (R)- and (S)-MTPA esters of mixture of 4 and 5 were produced using the general Mosher reaction procedure.

1H NMR data of the (R)-MTPA ester of 4 (400 MHz, pyridine-d5) (S44, Supporting Information): δ 5.506 (1H, m, H-3), 4.557 (1H, dd, J = 11.2, 1.4 Hz, H-1), 3.532 (1H, m, H-5), 2.775 (2H, m, H-7), 2.441 (1H, m, H-2a), 2.092 (1H, m, H-4a), 1.727 (1H, m, H-2b), 1.453 (1H, m, H-4b), 1.913 (1H, m, H-6a), 1.772 (1H, m, H-6b).

1H NMR data of the (S)-MTPA ester of 4 (400 MHz, pyridine-d5) (S46, Supporting Information): δ 5.509 (1H, m, H-3), 4.545 (1H, dd, J = 11.2, 1.6 Hz, H-1), 3.550 (1H, m, H-5), 2.789 (2H, m, H-7), 2.382 (1H, m, H-2a), 2.173 (1H, m, H-4a), 1.960 (1H, m, H-6a), 1.811 (1H, m, H-6b), 1.636 (1H, m, H-2b), 1.567 (1H, m, H-4b).

Preparation of the (R)- and (S)-MTPA Ester Derivatives of 6

The (R)- and (S)-MTPA esters of 6 were produced by following the general Mosher reaction procedure.

1H NMR data of the (R)-MTPA ester of 6 (400 MHz, pyridine-d5) (S48, Supporting Information): δ 7.872 (1H, d, J = 16.7 Hz, H-1), 7.040 (1H, d, J = 16.7 Hz, H-2), 6.083 (1H, m, H-5), 3.205 (1H, dd, J = 17.2, 4.1 Hz, H-4b), 2.642 (2H, m, H-7), 2.097 (2H, m, H-6).

1H NMR data of the (S)-MTPA ester of 6 (400 MHz, pyridine-d5) (S50, Supporting Information): δ 7.785 (1H, d, J = 16.5 Hz, H-1), 6.949 (1H, d, J = 16.5 Hz, H-2), 6.103 (1H, m, H-5), 3.144 (1H, dd, J = 17.1, 4.4 Hz, H-4b), 2.816 (2H, m, H-7), 2.186 (2H, m, H-6).

Preparation of the (R)- and (S)-MTPA Ester Derivatives of 8 and 9

The (R)- and (S)-MTPA esters of the mixture of 8 and 9 obtained from the isolation scheme were produced by following the same general Mosher reaction procedure. The 1H NMR spectra of the (R)- and (S)-MTPA esters of 8 and 9 (400 MHz, pyridine-d5), see Figures S52 and S54 in Supporting Information.

Supplementary Material

Supporting Information

ACKNOWLEDGMENT

The authors thank Dr. José G. Napolitano for his kind assistance with HiFSA procedures. We are also thankful to Dr. J. B. McAlpine for his valuable comments and suggestions during the manuscript preparation. This research was supported by grant P50AT000155 (UIC/NIH Botanical Center), co-funded by the National Center for Complementary and Alternative Medicine (NCCAM) and the Office of Dietary Supplements (ODS), both of the National Institutes of Health.

Footnotes

Residual Complexity and Bioactivity, Part 16 (see S1, Supporting Information)

ASSOCIATED CONTENT

The IR, 1D and 2D NMR spectra of compounds 17, the 1H NMR and 1H-1H COSY spectra of the (R)- and (S)-MTPA esters of the compounds 16, 8 and 9, the 1H NMR spectra of compounds 814, and the HiFSA simulated 1H NMR spectra of 17. This material is available free of charge via the Internet at http://pubs.acs.org.

REFERENCES

  • (1).Yoon KD, Chin YW, Yang MH, Choi J, Kim J. Phytochem. Anal. 2012;23:462–468. doi: 10.1002/pca.2342. [DOI] [PubMed] [Google Scholar]
  • (2).Carroll DG. Am. Fam. Physician. 2006;73:457–464. [PubMed] [Google Scholar]
  • (3).Marker RE, Turner DL, Ulshafer PR. J. Am. Chem. Soc. 1940;62:2542–2543. [Google Scholar]
  • (4).Dragomirescu A, Muresan A, Alexa E, Andoni M. Acta Endocrinol.-Buch. 2009;5:41–47. [Google Scholar]
  • (5).Marker RE, Wagner RB, Ulshafer PR, Wittbecker EL, Goldsmith DPJ, Ruof CH. J. Am. Chem. Soc. 1947;69:2167–2230. doi: 10.1021/ja01201a032. [DOI] [PubMed] [Google Scholar]
  • (6).Aradhana, Rao AR, Kale RK. Indian J. Exp. Biol. 1992;30:367–370. [PubMed] [Google Scholar]
  • (7).Djerassi C. Steroids. 1992;57:631–641. doi: 10.1016/0039-128x(92)90016-3. [DOI] [PubMed] [Google Scholar]
  • (8).Komesaroff PA, Black CVS, Cable V, Sudbir K. Climacteric. 2001;4:144–150. [PubMed] [Google Scholar]
  • (9).Hooker E. Int. J. Toxicol. 2004;23:49–54. [Google Scholar]
  • (10).Sautour M, Miyamoto T, Lacaille-Dubois MA. Biochem. Syst. Ecol. 2006;34:60–63. [Google Scholar]
  • (11).Hayes PY, Lambert LK, Lehmann R, Penman K, Kitching W, De Voss JJ. Magn. Reson. Chem. 2007;45:1001–1005. doi: 10.1002/mrc.2071. [DOI] [PubMed] [Google Scholar]
  • (12).Yoon KD, Kim J. J. Sep. Sci. 2008;31:2486–2491. doi: 10.1002/jssc.200800136. [DOI] [PubMed] [Google Scholar]
  • (13).Qiu F, Imai A, McAlpine JB, Lankin DC, Burton I, Karakach T, Farnsworth NR, Chen SN, Pauli GF. J. Nat. Prod. 2012;75:432–443. doi: 10.1021/np200878s. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (14).Gödecke T, Nikolic D, Lankin DC, Chen SN, Powell SL, Dietz B, Bolton JL, van Breemen RB, Farnsworth NR, Pauli GF. Phytochem. Anal. 2009;20:120–133. doi: 10.1002/pca.1106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (15).Lv H, She G. Nat. Prod. Commun. 2010;5:1687–1708. [PubMed] [Google Scholar]
  • (16).Yin J, Kouda K, Tezuka Y, Tran QL, Miyahara T, Chen Y, Kadota S. Planta Med. 2004;70:54–58. doi: 10.1055/s-2004-815456. [DOI] [PubMed] [Google Scholar]
  • (17).Wang Y, Liu Y, Yin J. Shenyang Yaoke Daxue Xuebao. 2007;24:374–379. [Google Scholar]
  • (18).Yin J, Liu Z, Wang Y, Chen Y, Kadota S. Zhongguo Xiandai Zhongyao. 2006;8:16–19. [Google Scholar]
  • (19).Liu H, Tsim KWK, Chou GX, Wang JM, Ji LL, Wang ZT. Chem. Biodivers. 2011;8:2110–2116. doi: 10.1002/cbdv.201000279. [DOI] [PubMed] [Google Scholar]
  • (20).Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Cell. Mol. Life Sci. 2008;65:1631–1652. doi: 10.1007/s00018-008-7452-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (21).Sharma RA, McLelland HR, Hill KA, Ireson CR, Euden SA, Manson MM, Pirmohamed M, Marnett LJ, Gescher AJ, Steward WP. Clin. Cancer Res. 2001;7:1894–1900. [PubMed] [Google Scholar]
  • (22).Sharma RA, Euden SA, Platton SL, Cooke DN, Shafayat A, Hewitt HR, Marczylo TH, Morgan B, Hemingway D, Plummer SM, Pirmohamed M, Gescher AJ, Steward WP. Clin. Cancer Res. 2004;10:6847–6854. doi: 10.1158/1078-0432.CCR-04-0744. [DOI] [PubMed] [Google Scholar]
  • (23).Ohtani I, Kusumi T, Kashman Y, Kakisawa H. J. Am. Chem. Soc. 1991;113:4092–4096. [Google Scholar]
  • (24).Rieser MJ, Hui YH, Rupprecht JK, Kozlowski JF, Wood KV, McLaughlin JL, Hanson PR, Zhuang Z, Hoye TR. J. Am. Chem. Soc. 1992;114:10203–10213. [Google Scholar]
  • (25).Lee S. Chem. Educator. 2004;9:359–363. [Google Scholar]
  • (26).Cordero FM, Pisaneschi F, Salvati M, Valenza S, Faggi C, Brandi A. Chirality. 2005;17:149–153. doi: 10.1002/chir.20139. [DOI] [PubMed] [Google Scholar]
  • (27).Gödecke T, Pauli GF. Phytochem. Anal. 2012 In Preparation, Submission Scheduled for 12, 2012. [Google Scholar]
  • (28).Choi SZ, Kwon HC, Chung AK, Choi SU, Kim KR, Lee SM, Pyo SN, Lee KR. Yakhak Hoechi. 2001;45:591–598. [Google Scholar]
  • (29).Li J, Liao CR, Wei JQ, Chen LX, Zhao F, Qiu F. Bioorg. Med. Chem. Lett. 2011;21:5363–5369. doi: 10.1016/j.bmcl.2011.07.012. [DOI] [PubMed] [Google Scholar]
  • (30).Ohta S, Koyama M, Aoki T, Suga T. Bull. Chem. Soc. Jpn. 1985;58:2423–2424. [Google Scholar]
  • (31).Ali MS, Tezuka Y, Awale S, Banskota AH, Kadota S. J. Nat. Prod. 2001;64:289–293. doi: 10.1021/np000496y. [DOI] [PubMed] [Google Scholar]
  • (32).Wu FJ, Su JD. J. Chin. Agric. Chem. Soc. 1996;34:438–451. [Google Scholar]
  • (33).Yokosuka A, Mimaki Y, Sakagami H, Sashida Y. J. Nat. Prod. 2002;65:283–289. doi: 10.1021/np010470m. [DOI] [PubMed] [Google Scholar]
  • (34).Dong H, Chen SX, Xu HX, Kadota S, Namba T. J. Nat. Prod. 1998;61:142–144. doi: 10.1021/np970293i. [DOI] [PubMed] [Google Scholar]
  • (35).Napolitano JG, Gödecke T, Rodriguez-Brasco MF, Jaki BU, Chen SN, Lankin DC, Pauli GF. J. Nat. Prod. 2012;75:238–248. doi: 10.1021/np200949v. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (36).Qiu F, Friesen JB, McAlpine JB, Pauli GF. J. Chromatogr. A. 2012;1242:26–34. doi: 10.1016/j.chroma.2012.03.081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (37).Pauli GF, Gödecke T, Jaki BU, Lankin DC. J. Nat. Prod. 2012;75:834–851. doi: 10.1021/np200993k. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (38).Qiu F. Ph.D. Dissertation. University of Illinois at Chicago; Chicago, IL United States: 2012. The Complexity of Natural Products at the Chemistry-Biology Interface. [Google Scholar]
  • (39).Gödecke T, Yao P, Napolitano JG, Nikolic D, Dietz BM, Bolton JL, van Breemen RB, Farnsworth NR, Chen SN, Lankin DC, Pauli GF. Fitoterapia. 2012;83:18–32. doi: 10.1016/j.fitote.2011.08.017. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

RESOURCES